Blood proteins linked to cognitive response in lifestyle trial
Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.

Our read
Interventions- Studied:
- Preprint: study of 1,158 older adults at risk of dementia
- What changed:
- Eleven proteins were linked to differences in thinking benefits from the lifestyle intervention
- The catch:
- Proteins could mark other biological processes rather than contribute directly to cognitive benefits
- In the record:
- The 120th paper on multidomain lifestyle intervention with results in people; 212 on record in all.
Editor of record: Boris Djordjevic · AgingResearch.News
Blood proteins from 1,158 older adults at risk of dementia were measured in an analysis of the FINGER trial, which tested a lifestyle intervention with several components. The trial had found benefits for cognition, or thinking abilities.
Ten proteins spanning immune, nerve-cell and metabolic processes were associated with poorer patterns of cognitive change, independently of the intervention. The intervention led to changes in eight proteins. Eleven proteins were linked to differences in cognitive response to the intervention. A complementary statistical analysis supported one of these response markers and identified additional ones. Some protein associations with intervention response differed by sex.
Why it matters
The authors suggest that these protein patterns could inform more personalized dementia prevention for older adults.
Caveats
The protein associations leave open whether the proteins contributed to cognitive benefits or reflected other processes. The report is a preprint and has not been peer-reviewed.
The paper
Karolinska Institutet
medRxiv, Nov 15, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed



Comments
Be the first to comment.